| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0089 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |